Lung cancer is a major issue in oncology pathology worldwide. According to the WHO, this disease is the number one cause of death in both men and women worldwide [1]. Worldwide The countries with the highest incidence of lung cancer meet in Polynesia and Hungary [2]. in Europe in 2018 According to the data provided by GLOBOCAN, the incidence of lung cancer was 470,039 new cases, of which 311,843 men and 158 196 women [3]. The highest incidence was in Hungary, Austria, Germany, Slovenia, Latvia, Romania, the last places being Portugal, Malta, Lichtenstein [4]. For the correct analysis of the survival rate of patients diagnosed with lung cancer, the tumor stage (microcellular lung cancer and non-microcellular lung cancer) were considered; histopathological type (adenocarcinoma, squamous cell carcinoma, neuroendocrine lung tumors - small cell carcinoma, carcinoid; type of treatment (surgical, surgery-chemotherapy, surgery-radiotherapy, surgery-chemo-radiotherapy) [5]. Advanced lung cancer has an extremely poor prognosis, with a 5-year survival of only 5% [6]. An early diagnosis of lung cancer is needed to increase survival. A rapid personalized diagnosis (molecular, imaging, anatomopathological, immunohistochemical) is required in order to initiate an early personalized treatment [7]. After establishing the personalized diagnosis, the therapeutic attitude in the case of lung cancer the treatment can be started [8]. In this context, Molecular diagnosis of lung cancer can be made in the early stages of the disease.
Keywords:
Published on: May 18, 2020 Pages: 26-29
Full Text PDF
Full Text HTML
DOI: 10.17352/2455-3484.000033
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."